Patheon has completed a $26-million expansion project at its Greenville, North Carolina manufacturing site that updates one of its sterile Pharmaceutical Development Services (PDS) suites and adds a sterile PDS suite. The PDS Suites 1 and 2 provide 7,000-square-feet in GMP sterile manufacturing space.

The newly built PDS suite will manufacture sterile liquid and lyophilized drug products. It features freeze dryers, a filling line fitted with a restricted access barrier system (RABS) for sterile drug products, and disposable manufacturing to eliminate the need for cleaning verification for liquid filling. This suite is designed for products in clinical development with the ability to scale up to larger batch sizes via Patheon’s network of commercial-scale capabilities either co-existing within the Greenville facility or in facilities in Europe.

Patheon’s Greenville manufacturing site is a large multi-purpose pharmaceutical manufacturing and packaging campus. The facility provides both solid dose form manufacturing/packaging and sterile dose manufacturing, filling, and lyophilization of biopharmaceuticals and small molecules and also has a continuous manufacturing suite.

Source: Patheon